CULLINAN THERAPEUTICS INC
CGEMNASDAQ🏆 #2539 by market capEarnings Nov 4US Equity
$245.50▲ $8.37 (+3.41%)
Simulated priceTrack CGEM
Get earnings, price moves & breaking news on Telegram
24h▲ 3.4%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$910M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
76
Good
CULLINAN THERAPEUTICS INC
CGEMAnalyst Ratings
Price
$245.50
Total
8
Raised
0
Lowered
0
Avg PT
$34.75
H / L
$40 / $27
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-25 | — | — |
BTIG | Reiterated | Buy | 2026-09-25 | $40.00 | −83.70% |
Wedbush | Reiterated | Outperform | 2026-08-13 | $37.00 | −84.90% |
Morgan Stanley | Reiterated | Overweight | 2025-08-18 | $30.00 | −87.80% |
UBS | Reiterated | Buy | 2025-05-12 | $27.00 | −89.00% |
Stifel | Reiterated | Buy | 2025-02-28 | — | — |
JonesTrading | Reiterated | Buy | 2024-04-17 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-05-13 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-25
—
—
BTIG
Reiterated · Buy · 2026-09-25
$40.00
−83.70%
Wedbush
Reiterated · Outperform · 2026-08-13
$37.00
−84.90%
Morgan Stanley
Reiterated · Overweight · 2025-08-18
$30.00
−87.80%
UBS
Reiterated · Buy · 2025-05-12
$27.00
−89.00%
Stifel
Reiterated · Buy · 2025-02-28
—
—
JonesTrading
Reiterated · Buy · 2024-04-17
—
—
SVB Leerink
Reiterated · Outperform · 2022-05-13
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space